Riskpilot← Back to searchSign inGet full accessMedetect AB
ABActiveOrg 5567579833Scheelevägen 2Other human health activities n.e.c. · NACE 8699Est. 20085 employees
Revenue 2025
SEK 15,5M
+57% vs 2024
EBITDA margin
49.2%
+176% vs 2024
Equity ratio
59.1%
Financial strength
Net profit 2025
SEK 4,5M
+72% vs 2024
| Revenue | SEK 15,5M | +57% |
| EBITDA | SEK 7,6M | +176% |
| Net profit | SEK 4,5M | +72% |
| Total assets | SEK 16,9M | +55% |
| Equity | SEK 10M | +54% |
| Employees | 5 | — |
Legal name
Medetect AB
Org number
5567579833
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
15 maj 2008
Share capital
SEK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets verksamhet kommer att vara ett kunskapsföretag med konsultverksamhet inom det medicinska området. Specifikt kommer vi att erbjuda läkemedelsföretag tjänster för rådgivning och analys i samband med utvärderingen av nya läkemedelskandidater. Företaget kommer även att ha en liten intern teknikutveckling i syfte att förbättra våra konsulttjänster.
Address
Scheelevägen 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 587 | 11 496 | 8 416 | 9 828 | 15 463 |
| Staff expenses | — | — | — | −3 597 | −3 817 |
| EBITDA | 2 966 | 3 015 | 2 416 | 2 761 | 7 613 |
| Depreciation & amort. | −250 | −247 | −234 | −222 | −274 |
| EBIT | 2 716 | 2 768 | 2 182 | 2 538 | 7 338 |
| Net financials | −2 | −4 | 3 | 49 | 123 |
| Profit before tax | 2 064 | 2 265 | 2 185 | 3 307 | 5 662 |
| Tax | −451 | −479 | −468 | −710 | −1 184 |
| Net profit | 1 613 | 1 786 | 1 717 | 2 597 | 4 477 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 804 | 11 736 | 10 760 | 10 902 | 16 853 |
| Equity | 4 140 | 4 101 | 4 838 | 6 456 | 9 953 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 2 514 | 4 717 | 3 271 | 2 517 | 3 171 |
| Total debt | 2 514 | 4 717 | 3 271 | 2 517 | 3 171 |
EBITDA margin
49.2%
This company
15.8%
Market median
+211% vs market
20212025
Equity ratio
59.1%
This company
38.2%
Market median
+55% vs market
20212025
Return on equity
45.0%
This company
18.4%
Market median
+145% vs market
20212025
Net profit margin
29.0%
This company
8.1%
Market median
+258% vs market
20212025
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
20212025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ST Chief Auditor | Chief Auditor | 2024 |
| Former (1) | ||
MA Chief Auditor | Chief Auditor | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medetect AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Ann Lorentz | Chief Auditor | 0 companies |
| Sandra Theresa Meijer | Chief Auditor | 0 companies |
| Gunn Monika Kathrine Malm Erjefält | Board of Directors | 0 companies |
| Hans Lennart Erjefält | Deputy Board Member | 0 companies |
| Sten Jonas Erjefält | Chairman | 0 companies |
| David Stig Erjefält | Deputy Board Member | 0 companies |